Please find enclosed Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for quarter ended 31st March, 2025 for your reference
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has submitted a routine compliance certificate to BSE for the quarter ended 31 March 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (Adroit Corporate Services Pvt. Ltd.), confirms that all securities received from depository participants for dematerialisation during the quarter were properly processed and confirmed to the depositories. It also confirms that physical share certificates received for demat were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's register of members within the 15-day SEBI-prescribed timeline. This is a standard quarterly filing required under SEBI's DP Regulations and carries no financial numbers or strategic information.
This is a routine regulatory compliance submission with no material impact on the company's financials, operations, or share price. It simply demonstrates adherence to SEBI's procedural requirements for handling dematerialised securities.